Selinexor, a Selective Inhibitor of Nuclear Export (SINE), Enhances the In Vivo Efficacy of Checkpoint Blockade with Antibodies Targeting CTLA4 or PD-1/PD-L1 in Melanoma
Selinexor, a Selective Inhibitor of Nuclear Export (SINE), Enhances the In Vivo Efficacy of Checkpoint Blockade with Antibodies Targeting CTLA4 or PD-1/PD-L1 in Melanoma